Lipid environment modulates the development of acute tolerance to ethanol in Caenorhabditis elegans.

PloS One
Jill C BettingerAndrew G Davies

Abstract

The development of tolerance to a drug at the level of the neuron reflects a homeostatic mechanism by which neurons respond to perturbations of their function by external stimuli. Acute functional tolerance (AFT) to ethanol is a fast compensatory response that develops within a single drug session and normalizes neuronal function despite the continued presence of the drug. We performed a genetic screen to identify genes required for the development of acute functional tolerance to ethanol in the nematode C. elegans. We identified mutations affecting multiple genes in a genetic pathway known to regulate levels of triacylglycerols (TAGs) via the lipase LIPS-7, indicating that there is an important role for TAGs in the development of tolerance. Genetic manipulation of lips-7 expression, up or down, produced opposing effects on ethanol sensitivity and on the rate of development of AFT. Further, decreasing cholesterol levels through environmental manipulation mirrored the effects of decreased TAG levels. Finally, we found that genetic alterations in the levels of the TAG lipase LIPS-7 can modify the phenotype of gain-of-function mutations in the ethanol-inducible ion channel SLO-1, the voltage- and calcium-sensitive BK channel. This...Continue Reading

References

Dec 5, 1974·Journal of Molecular Biology·H F EpsteinS Brenner
Jan 1, 1984·Annual Review of Pharmacology and Toxicology·D B Goldstein
Jun 1, 1994·The Journal of Membrane Biology·T Weiger, A Hermann
Feb 1, 1994·The American Journal of Psychiatry·M A Schuckit
Mar 1, 1996·Archives of General Psychiatry·M A Schuckit, T L Smith
Jul 22, 1999·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·P Thompson
Nov 27, 1999·Psychological Medicine·A C HeathN G Martin
Jun 29, 2000·Biochemical and Biophysical Research Communications·J L Watts, J Browse
Feb 13, 2001·Pharmacology, Biochemistry, and Behavior·T E ThieleR D Palmiter
Jun 18, 2002·The Journal of Pharmacology and Experimental Therapeutics·Igor Ponomarev, John C Crabbe
Jan 18, 2003·Developmental Cell·Renée M McKayJonathan M Graff
Mar 22, 2003·The Journal of Pharmacology and Experimental Therapeutics·W R ProctorT V Dunwiddie
Oct 2, 2003·Nature·Stephen J AnsleyNicholas Katsanis
Jul 13, 2005·The Journal of Biological Chemistry·Neesha SuvarnaDorit Ron
Sep 15, 2005·BMC Genomics·M Wayne DavisErik M Jorgensen
Mar 17, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Melisa J WallaceRobert O Messing
Jan 9, 2007·The Journal of Biological Chemistry·Chunbo YuanSteven N Treistman
Sep 1, 2007·Molecular Biology of the Cell·Doreen R GlodowskiChristopher Rongo
Nov 17, 2007·Journal of Molecular Biology·Hannah R NicholasMerlin Crossley
Dec 18, 2007·The Journal of Biological Chemistry·Chunbo YuanSteven N Treistman
Mar 4, 2008·British Journal of Pharmacology·V VengelieneR Spanagel
Jul 18, 2008·Science Signaling·R Adron HarrisS John Mihic
Jan 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Shuzhen ChenYang Shi
May 22, 2009·Nature·Rob PhillipsPierre Sens
Sep 29, 2009·Trends in Neurosciences·Steven N Treistman, Gilles E Martin
Feb 18, 2010·Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies·Penelope A LindPamela A F Madden
Apr 6, 2011·Alcoholism, Clinical and Experimental Research·Smita GhareSwati Joshi-Barve
Oct 30, 2013·Nature Neuroscience·Chunghun Lim, Ravi Allada

❮ Previous
Next ❯

Citations

Jun 14, 2014·Proceedings of the National Academy of Sciences of the United States of America·Anna N BukiyaAlex M Dopico
Nov 18, 2015·Cancer Biology & Therapy·Rajani KantetiRavi Salgia
Feb 26, 2015·Proceedings of the National Academy of Sciences of the United States of America·Laura D MathiesJill C Bettinger
Feb 5, 2013·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·John Ramcharitar, Ronnie M Ibrahim
Jul 16, 2015·Alcoholism, Clinical and Experimental Research·Mike Grotewiel, Jill C Bettinger
Jun 3, 2014·Developmental Biology·Duygu YücelHannah R Nicholas
Sep 25, 2014·Frontiers in Physiology·Jill C Bettinger, Andrew G Davies
Nov 2, 2016·The Journal of General Physiology·Guruprasad Kuntamallappanavar, Alex M Dopico
Feb 23, 2017·Alcoholism, Clinical and Experimental Research·Amy E AdkinsBrien P Riley
Jan 4, 2017·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Jacquelyn L MeyersBernice Porjesz
Jul 25, 2013·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·James DillonLindy Holden-Dye
May 20, 2020·Alcoholism, Clinical and Experimental Research·Youngki You, Joydip Das
Jul 23, 2016·Nature Reviews. Neuroscience·Dorit Ron, Segev Barak
May 28, 2021·Scientific Reports·Mark G SterkenJill C Bettinger

❮ Previous
Next ❯

Software Mentioned

ImagePro plus

Related Concepts

Related Feeds

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.